Drug Type Synthetic peptide |
Synonyms |
Target |
Action antagonists |
Mechanism TRPV1 antagonists(Transient receptor potential cation channel subfamily V member 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis | Discovery | South Korea | 30 Oct 2023 |